Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 15/20 | 0.55 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30464946 | 1.00 | CTSK (0.55) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL4781261 | 1.00 | CTSK (0.55) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL28398590 | 0.98 | CTSK (0.56) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL24739376 | 0.98 | CTSK (0.56) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL24465592 | 0.98 | CTSK (0.56) | CTSKCTSSCA1CA2CA7 | |
| Hydrochloric Acid SCHEMBL30306646 | 0.97 | CTSK (0.55) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL12734600 | 0.93 | CTSK (0.61) | CTSKCTSS | |
| SCHEMBL12734596 | 0.93 | CTSK (0.61) | CTSKCTSS | |
| SCHEMBL15961701 | 0.93 | CTSK (0.61) | CTSKCTSS | |
| SCHEMBL8314800 | 0.87 | TDP1 (0.56) | CTSKCTSSCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113135921-A | Dihydropyrimidine-spiro derivative and preparation method and application thereof | 山东大学 | 2021-07-20 | — | — | CN | claimed |
| CN-117794936-A | Novel PLK1 degradation inducing compounds | 厄普特拉株式会社 | 2024-03-29 | — | — | CN | disclosed |
| CN-113302196-B | EGFR inhibitor, composition and application thereof | 贝达药业股份有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-116529246-A | N- [ (1, 3-benzoxazol-2-yl) -heterocycle ] amide derivatives for the treatment and prevention of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116261458-A | Novel PLK1 degradation inducing compounds | 厄普特拉株式会社 | 2023-06-13 | — | — | CN | disclosed |
| CN-113135921-B | Dihydropyrimidine-spiro derivative and preparation method and application thereof | 山东大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-113825748-A | Antimicrobial compounds and methods | 库扎环球有限责任公司 | 2021-12-21 | — | — | CN | disclosed |
| CN-113302196-A | EGFR inhibitor and composition and application thereof | 贝达药业股份有限公司 | 2021-08-24 | — | — | CN | disclosed |
| CN-113135921-A | Dihydropyrimidine-spiro derivative and preparation method and application thereof | 山东大学 | 2021-07-20 | — | — | CN | disclosed |